Machine Learning Prediction of Parameters of Early Warning Scores in Intensive Care Units (AIM-PEW-ICU)

October 12, 2024 updated by: Kepler University Hospital
A large number of different organ functions are recorded in real time for patients being monitored in an intensive care unit. On the one hand, the measured values collected are used for continuous monitoring of vital parameters, e.g. blood pressure, heart rate and respiratory rate, but are also evaluated several times a day in conjunction with other data as part of ward rounds. In both cases, continuous monitoring from a limited number of parameters, but also in the distinct evaluation with a more extensive set of analyzable parameters, there are limitations in the evaluability even with all the care and expertise available: In continuous analysis, interpretation is limited by the restricted number of continuously recorded parameters described above. Although a large number of such measurements are possible, and at least theoretically a larger number of parameters could be measured, patient-specific limits such as patient cooperation, medical limits such as the significance of the measured values in specific situations, but also economic limits are often decisive in this context. Although accurate conclusions can be drawn from the continuous and therefore complete representation of aspects of human physiology, the limitation of the available parameters reduces the interpretability of the synthesis of different statuses. In the broader, more comprehensive assessments during visits at specific points in time, on the other hand, there are limitations due to, among other things, point recordings of individual measured values and the predefined visit times. Even if limit values are (or can be) defined for the measured data, and a consequence, e.g. a therapy step, is initiated if these values are exceeded or not reached, this alert can only be initiated retrospectively if these values are exceeded and a consequence can only be initiated retrospectively. In this situation, a pathophysiological change is already so far advanced that in many cases a compensation mechanism no longer functions adequately and turns into a decompensation situation. In this situation, the patients affected in an intensive care unit are in many cases in mortal danger. Both situations, continuous recording of a limited number of parameters and the evaluation of extensive data in the form of a snapshot could be optimized despite the limitations mentioned. Without changing the collection of data (time, scope, etc.), the possibilities for optimizing their interpretation and the consequences that can be derived from the interpretation remain. The interpretation of the data is primarily determined by the interpreters as the method of interpretation. Current approaches attempt to use machine learning (ML) methods to predict individual situations that recognize adverse events in the given data and at the same time allow alarms to be triggered pre-emptively, i.e. before a life-threatening situation occurs. Furthermore, there are already studies on the change of early warning scores in time series, which are, however, limited in their informative value for longer prediction periods.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

8000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Upper Austria
      • Linz, Upper Austria, Austria, 4020
        • Kepler University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients treated in intensive care.

Description

Inclusion Criteria:

  • Treated in intensive care between 2010-01-01 and 2023-12-31 at the study center.

Exclusion Criteria:

  • None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
AUC-ROC for Prediction of Parameters of Early Warning Scores
Time Frame: 2010-01-01 to 2023-12-31
AUC-ROC for Prediction of Parameters of Early Warning Scores
2010-01-01 to 2023-12-31
AUC-PRC for Prediction of Parameters of Early Warning Scores
Time Frame: 2010-01-01 to 2023-12-31
AUC-PRC for Prediction of Parameters of Early Warning Scores
2010-01-01 to 2023-12-31
F1-Score for Prediction of Parameters of Early Warning Scores
Time Frame: 2010-01-01 to 2023-12-31
F1-Score for Prediction of Parameters of Early Warning Scores
2010-01-01 to 2023-12-31
Confusion Matrix for Prediction of Parameters of Early Warning Scores
Time Frame: 2010-01-01 to 2023-12-31
Confusion Matrix for Prediction of Parameters of Early Warning Scores
2010-01-01 to 2023-12-31

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SHAP Values for Prediction Models
Time Frame: 2010-01-01 to 2023-12-31
SHAP Values for Prediction Models
2010-01-01 to 2023-12-31
Confusion Matrix for Prediction of In Hospital-Mortality
Time Frame: 2010-01-01 to 2023-12-31
Confusion Matrix for Prediction of In Hospital-Mortality
2010-01-01 to 2023-12-31

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jens Meier, MD, Johannes Kepler University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Actual)

September 15, 2024

Study Completion (Estimated)

September 15, 2025

Study Registration Dates

First Submitted

February 7, 2024

First Submitted That Met QC Criteria

February 7, 2024

First Posted (Actual)

February 14, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 12, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • AIM-PEW-ICU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Safety

Clinical Trials on Parameters of Early Warning Scores

Subscribe